DrugInformer Search

Namenda Related Adverse drug reaction

Official Government Database Reports10
Online Conversations2
Share

Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients. To view the active ingredient report, please click here.


Tell us about your Experience with Namenda

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Back pain, Hypersomnia, Walking disability, Muscular weakness, Somnolence, Adverse drug reaction

Posted By Anonymous in askapatient.com on February 11, 2015 @ 12:00 am

Side Effects: My client experienced back pain legs were so weak couldn't walk and very very fatigue all he did was fall asleep, did not find namenda helpful at all ,only made things worse. ...

Druginformer Identified Side Effects: Adverse drug reaction

Posted By edw in fdb.rxlist.com on July 1, 2014 @ 12:00 am

I take one a day Namanda 5 plus one Galantamine HBr 8mg. Do not seem to suffer any side effects. I feel they are holding my problem steady at the moment. I tried Aricept and others but had bad side ef...


* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.